Clinical Trial Update: Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD [Phase 1]

View source ↗

Summary

The FREEDMM trial is a Phase 1 study investigating whether patients with multiple myeloma can discontinue maintenance therapy based on minimal residual disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING